Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma

doi:10.3748/wjg.v11.i36.5685

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2470)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

229

HTML

1853

Figures (1-2)

206

Tables (1-2)

182

Sum=2470

Sep 28, 2005 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 28, 2005; 11(36): 5685-5687
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5685

Open in New Tab Full Size Figure Download Figure

Figure 1 Regimen for IFNα plus 5-FU combination therapy (one cycle).

Open in New Tab Full Size Figure Download Figure

Figure 2 CT of a patient who showed a complete response. Enhanced lesions of HCC (arrows) disappeared after three cycles of combination therapy with IFNα and 5-FU. The serum levels of AFP are also presented.

Citation: Enjoji M, Morizono S, Kotoh K, Kohjima M, Miyagi Y, Yoshimoto T, Nakamuta M. Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma. World J Gastroenterol 2005; 11(36): 5685-5687
URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5685.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5685